Clinical Trial Update: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of AR882 with a xanthine oxidase inhibitor co-administration in gout patients who failed uricase thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Gouty Arthritis
• Hyperuricemia
• Tophaceous Gout
• Uncontrolled Gout

Drugs mentioned

• AR882
• XOI (xanthine oxidase inhibitor)

Snippet

Sponsor: Arthrosi Therapeutics | Conditions: Gout, Gouty Arthritis | Phase 2 | Status: RECRUITING